MUC2 Antibody (Rabbit mAb) [M5E4]

CatNo: F9896

    Application: Reactivity:
    • Lane 1: Caco-2
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%

    使用情報

    Dilution
    1:500-1:1000
    1:15000
    Application
    WB, IP, ELISA
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    551 kDa 110 kDa, 130 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human colon tissue; Human small intestine tissue; Human colonic adenocarcinoma tissue; Caco-2 cells; SK-BR-3 cells; HT-1376 cells; SH-SY5Y cells
    ネガティブコントロール Human breast carcinoma tissue; Human tonsil tissue; Human skeletal muscle tissue; Human brain tissue

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use primary antibody dilution buffer to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    MUC2 Antibody (Rabbit mAb) [M5E4] detects endogenous levels of total MUC2 protein.
    タンパク質の局在
    細胞外環境
    Uniprot ID
    Q02817
    Clone
    M5E4
    Synonym(s)
    SMUC, MUC2, Mucin-2, MUC-2, Intestinal mucin-2
    Background
    MUC2 belongs to the gel-forming mucin family, related structurally to von Willebrand factor, and serves as the principal building block of the intestinal mucus layers that physically separate the gut microbiota from the underlying epithelial surface. The protein carries an N-terminal region built from tandem von Willebrand D domains, VWD1, VWD2, and VWD'D3, interspersed with cysteine-rich CysD domains, a central region dominated by heavily O-glycosylated PTS domains rich in serine, threonine, and proline, and a C-terminal region containing a further VWD4 domain followed by roughly three and a half linear VWC domains and a terminal cystine-knot domain. Following synthesis, MUC2 first dimerizes in the endoplasmic reticulum through disulfide bonds formed between the cystine-knot domains at the C-termini of two monomers, and this C-terminal dimer is then translocated to the Golgi apparatus, where extensive O-glycosylation of the central PTS domains expands the molecule to a mass in the megadalton range. A structural model of the MUC2 C-terminal dimer, built by combining cryo-electron microscopy, computational structure prediction, and small-angle X-ray scattering, reveals that all gel-forming mucins and von Willebrand factor share the same tail-to-tail disulfide-linked dimer architecture at the cystine-knot domain, but MUC2 specifically carries an additional stabilizing disulfide bond positioned on the N-terminal side of its VWD4 domain, a feature not present in the other gel-forming mucins or in von Willebrand factor and proposed to be specifically required for the stability of the intestinal mucus barrier. Once C-terminal dimers are formed, a separate assembly step links the N-termini of multiple dimers together through additional disulfide bonds, producing a covalently connected polymeric network that is packaged into mucin granules within goblet cells before secretion. After secretion, this disulfide-stabilized polymeric skeleton undergoes proteolytic cleavage of the MUC2 protein core, and because these cleavage events occur without disrupting the underlying disulfide-bonded polymeric network, the mucus can expand substantially in volume while its structural continuity is preserved, converting the compact, firmly adherent mucus layer into the more voluminous, loosely organized outer layer. The resulting two-layer colonic mucus system depends entirely on this MUC2 polymer network: the inner layer remains firmly attached, compact, and impermeable to bacteria, physically excluding the intestinal microbiota from direct contact with the epithelium, while the outer layer, generated through proteolytic expansion of the same MUC2 network, provides the habitat in which commensal bacteria reside, and this microbial exclusion function of the inner MUC2 layer occurs independently of adaptive or innate immune mechanisms, since it is preserved even in germ-free animals. Disruption of MUC2 network assembly, folding, or its bacteria-excluding barrier function is implicated in ulcerative colitis, positioning both the disulfide-mediated polymerization interfaces and the proteolytically expandable network architecture as defined structural features relevant to intestinal barrier disease.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください